Clinical Edge Journal Scan

Mediterranean diet tied to reduced disease activity, disease impact, and functional disability in RA


 

Key clinical point: Higher adherence to the Mediterranean diet may help reduce disease impact, disease activity, and functional disability in patients with rheumatoid arthritis (RA).

Major finding: Patients with high vs low adherence to the Mediterranean diet had significantly lower Disease Activity Score of 28 Joints calculated with C-reactive protein (median 2.29 vs 3.27; P = .038), Health Assessment Questionnaire score (median 0.56 vs 1.00; P = .027), and Rheumatoid Arthritis Impact of Disease questionnaire score (median 3.51 vs 5.65; P = .032).

Study details: Findings are from a cross-sectional observational study including 120 patients with RA.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Charneca S et al. The Mediterranean diet, and not dietary inflammatory index, is associated with rheumatoid arthritis disease activity, the impact of disease and functional disability. Eur J Nutr. 2023 (Jun 24). Doi: 10.1007/s00394-023-03196-8

Recommended Reading

Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
MDedge Rheumatology
Antidrug antibody effects compared across RA biologics
MDedge Rheumatology
Humira biosimilars: Five things to know
MDedge Rheumatology
Tofacitinib shows marginal edge over adalimumab in real-world patients with RA
MDedge Rheumatology
Certolizumab pegol and abatacept show superiority over conventional therapy in early RA
MDedge Rheumatology
Joint involvement starts earlier and more severely in hands than in feet in RA
MDedge Rheumatology
Joint tenderness at 3 months post-diagnosis predicts long-term pain in early RA
MDedge Rheumatology
Small and favorable changes in body composition with low-dose prednisolone in elderly patients with active RA
MDedge Rheumatology
Exposure to volatile organic compounds raises risk for RA
MDedge Rheumatology
Concomitant ILD negatively affects clinical remission in RA
MDedge Rheumatology